GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Cyclically Adjusted FCF per Share

NeoPharm Co (XKRX:092730) Cyclically Adjusted FCF per Share : ₩1,733.13 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

NeoPharm Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ₩93.583. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩1,733.13 for the trailing ten years ended in Mar. 2024.

During the past 12 months, NeoPharm Co's average Cyclically Adjusted FCF Growth Rate was -2.00% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 15.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 22.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of NeoPharm Co was 29.00% per year. The lowest was 15.50% per year. And the median was 25.95% per year.

As of today (2024-05-22), NeoPharm Co's current stock price is ₩26950.00. NeoPharm Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ₩1,733.13. NeoPharm Co's Cyclically Adjusted Price-to-FCF of today is 15.55.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of NeoPharm Co was 141.08. The lowest was 9.90. And the median was 29.15.


NeoPharm Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for NeoPharm Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Cyclically Adjusted FCF per Share Chart

NeoPharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 908.23 1,140.61 1,408.35 1,698.18 1,755.99

NeoPharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,768.23 1,837.25 1,935.51 1,755.99 1,733.13

Competitive Comparison of NeoPharm Co's Cyclically Adjusted FCF per Share

For the Household & Personal Products subindustry, NeoPharm Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeoPharm Co's Cyclically Adjusted Price-to-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, NeoPharm Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where NeoPharm Co's Cyclically Adjusted Price-to-FCF falls into.



NeoPharm Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NeoPharm Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=93.583/118.8477*118.8477
=93.583

Current CPI (Mar. 2024) = 118.8477.

NeoPharm Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 154.158 99.353 184.406
201409 90.890 99.608 108.446
201412 396.937 99.098 476.044
201503 270.217 99.720 322.048
201506 83.412 100.050 99.084
201509 28.774 100.110 34.160
201512 368.402 100.220 436.876
201603 -56.229 100.560 -66.455
201606 353.672 100.790 417.036
201609 347.332 101.460 406.856
201612 445.152 101.560 520.926
201703 51.494 102.850 59.504
201706 470.604 102.610 545.076
201709 390.124 103.490 448.018
201712 420.641 102.990 485.408
201803 327.906 104.100 374.360
201806 564.280 104.130 644.035
201809 261.791 105.650 294.494
201812 817.205 104.350 930.742
201903 -221.292 104.490 -251.699
201906 1,028.906 104.880 1,165.934
201909 459.959 105.200 519.630
201912 1,015.574 105.120 1,148.199
202003 421.606 105.540 474.767
202006 312.824 104.870 354.519
202009 368.035 106.200 411.865
202012 970.671 105.765 1,090.735
202103 733.350 107.357 811.841
202106 617.282 107.579 681.944
202109 260.793 108.759 284.984
202112 1,092.455 109.676 1,183.808
202203 430.214 111.806 457.310
202206 493.329 114.083 513.934
202209 205.050 114.831 212.222
202212 1,089.492 115.200 1,123.988
202303 636.307 116.550 648.854
202306 651.090 117.140 660.582
202309 558.907 119.111 557.671
202312 -1,534.473 118.848 -1,534.473
202403 93.583 118.848 93.583

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


NeoPharm Co  (XKRX:092730) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

NeoPharm Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=26950.00/1733.13
=15.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of NeoPharm Co was 141.08. The lowest was 9.90. And the median was 29.15.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


NeoPharm Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


NeoPharm Co (XKRX:092730) Business Description

Traded in Other Exchanges
N/A
Address
928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510
NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines